Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals(RXRX.US) Director Sells US$104.94K in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on May 28, 2024 at an average price of $9.1677 for a total value of $104.94K.Source: Announcement What i
How Is The Market Feeling About Recursion Pharmaceuticals?
Recursion Pharmaceuticals's (NYSE:RXRX) short percent of float has risen 4.63% since its last report. The company recently reported that it has 42.37 million shares sold short, which is 26.88% of all
Hedge Funds Are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature Genetics scientific
Trending Industry Today: SoundHound AI Leads Losses In NVIDIA Holdings Stocks
May 29th - The industry of $NVIDIA Holdings(LIST20882.US)$ is trending down in regular trading hours with 4 constituents down and SoundHound AI leading Losses.$SoundHound AI(SOUN.US)$ slides 5.19% to
Revenues Not Telling The Story For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
With a price-to-sales (or "P/S") ratio of 46.2x Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) may be sending very bearish signals at the moment, given that almost half of all the Biotechs companies in
Form 144 | Recursion Pharmaceuticals(RXRX.US) Director Proposes to Sell 104.94K in Common Stocks
SEC FILLINGS DISCLOSED/ May 28, $Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake intends to sell 11,447 shares of its common stock on May 28, with a total market value of approximately $10
Trending Industry Today: Arm Holdings Leads Gains In NVIDIA Holdings Stocks
May 28th - The industry of $NVIDIA Holdings(LIST20882.US)$ is trending up in regular trading hours with 2 constituents up, 2 constituents down and Arm Holdings leading Gains.$Arm Holdings(ARM.US)$ up
Recursion Pharma Taps Hershberg as Next Chair to Succeed Chavez
By Dean Seal Recursion Pharmaceuticals is naming a new chair as Martin Chavez departs after four years at the board's helm. The clinical stage biotechnology company said Friday that it has tapped Dr
Express News | Recursion Pharmaceuticals Inc: Martin Chavez Exits
Here Is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) Is a Trending Stock
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a "terrific spec" and he recommended buying the same.On May 9, Recursion Pharmaceuticals reporte
Director Blake Borgeson Sells 20,054 Shares of Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals(RXRX.US) Director Sells US$202.93K in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 20,054 shares of common stock on May 14, 2024 at an average price of $10.1194 for a total value of $202.93K.Source: Announcement What
Form 144 | Recursion Pharmaceuticals(RXRX.US) Director Proposes to Sell 202.93K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake intends to sell 20,054 shares of its common stock on May 14, with a total market value of approximately $20
Express News | Recursion Pharmaceuticals Shares Are Trading Higher Possibly Amid Strength in High-short Interest Stocks After Retail Trader 'Roaring Kitty' Returned to Social Media. The Stock May Also Be Moving Amid Continued Strength After the Company Announced on...
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining around 20 points on Tuesday.Shares of Sony Group Corporation (NYSE:SONY) rose sharply during Tuesday's session after the company reported better-tha
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)
No Data